WRLD A.LIVE

23:003 reports

• Interpath-001: data leak, stock drop, spirited defense by ESMO president BioWorld News
• Individualizing Treatment in Multiple Myeloma CancerNetwork
• PFS, MRD, and Treatment Duration in Multiple Myeloma CancerNetwork

22:001 report

• Next-generation drug reduces endometrial cancer progression and death in trial Medical Xpress

21:004 reports

• Aydah AlAwadhi: Advancing Personalized mRNA Cancer Vaccines in High-Risk Melanoma Oncodaily
• Moderna seeks FDA approval for intismeran as soon as possible — STAT News UA.NEWS
• Psychological Distress Common in Patients With Cancer, Nurse Scientist Says Oncology Nursing News
• Population-Level Shifts in Cervical Cancer Stage Distribution in the United States Following Human Papillomavirus (HPV) Vaccine Implementation Cureus

20:004 reports

• In vivo engineered CAR NK cells Nature
• Two-Year Data of Pimicotinib Demonstrated Durable Tumor Control and Sustained Improvement in TGCT Symptoms and Joint Function – Company Announcement Financial Times
• How Cancer Cells React to Loss of Amino Acid Depends on Their Cell State Technology Networks
• IL-21 mimic synergizes with KRAS inhibitors Nature

19:006 reports

• Moderna Stock Forecast: MRNA Holds $181.36 Support After Positive Cancer Vaccine Data Sparks a Selloff TradingKey
• World-First Cancer Vaccine Cuts Melanoma Recurrence or Death Risk by 42% in Landmark Trial ScienceAlert
• [Column] Could cancer vaccines open a new era in cancer treatment? Korea Biomedical Review
• Torvu-Sam Elicits Responses & Manageable Safety Across FRα Expression Levels in PROC OncLive
• Cancer Findings Support Calls for Improved LP Care Medscape
• GBH Daily: An invitation WGBH

18:006 reports

• Personalized Melanoma Vaccine Improves RFS in Phase 3 Trial Medscape
• 'A new frontier': Though scorned by RFK Jr., personalized mRNA vaccine offers hope for many suffering from melanoma skin cancer Genetic Literacy Project
• Moderna CEO on what’s next after success in cancer vaccine STAT
• mRNA vaccine reduced risk of melanoma recurrence or death by 42% — ScienceAlert UA.NEWS
• Menna Fouda: What Should Oncologists Know About mRNA Cancer Vaccines? Oncodaily
• Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer NPR

17:003 reports

• A Single Case of Durable Nivolumab Response in Oropharyngeal Cancer Medscape
• Rare Nipple Melanoma Case Exposes Diagnostic Challenges EMJ
• SMART-KEY at ESMO 2026: Pembrolizumab-Based Strategy Achieves 65.1% Laryngectomy-Free Survival in Advanced Laryngeal Cancer Oncodaily

16:002 reports

• Interventional radiology underrepresented in cancer guideline development Radiology Business
• Fewer US men are diagnosed with low-risk prostate cancer, and more of them now choose surveillance over treatment Medical Xpress

15:00nothing heard

14:002 reports

• Beyond mutations: new study reveals alternative route to cancer Science Tokyo
• Research Finds Alternative Pathway to Cancer Beyond Mutations Mirage News

13:002 reports

• INTerpath-001 Data Detail Survival, Subgroup, and Safety Findings in Melanoma CancerNetwork
• #ESMO26: Merck and Moderna’s cancer vaccine data were ‘a triumph of science.’ And now, the work begins Endpoints News

12:005 reports

• The ESMO presentation everyone’s been waiting for STAT
• Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Drug Makers Report The New York Times
• Sinor Soltanizadeh: Could Personalized Cancer Vaccines Shape the Future of Gynaecological Oncology? Oncodaily
• MRNA: Intismeran plus pembrolizumab improved RFS and DMFS in phase III melanoma TradingView
• World-First Cancer Vaccine Cuts Melanoma Recurrence or Death Risk by 42% in Landmark Trial Yahoo

11:00nothing heard

10:00nothing heard

09:001 report

• Diffuse Large B-Cell Lymphoma Presenting as an Isolated Inguinal Mass in a 19-Year-Old Male Patient Cureus

08:00nothing heard

07:00nothing heard

06:00nothing heard

05:00nothing heard

04:003 reports

• 5 doctors weigh in on the promise, limitations of Grail’s multicancer test MedTech Dive
• J&J Reports 77% Response Rate For Rybrevant Faspro In First-Line Head And Neck Cancer TradingView
• New treatment combination shows promising results in recurrent head and neck cancer The Institute of Cancer Research

03:00nothing heard

02:002 reports

• New triple therapy could shrink cancer tumours LBC
• NRG-GY020 Trial Finds No Added Benefit of Pembrolizumab With Adjuvant Radiotherapy in Early-Stage Endometrial Cancer Oncodaily

01:001 report

• AGITG MASTERPLAN Trial Shows Improved Local Control and Survival With SBRT Plus Chemotherapy in Pancreatic Cancer Oncodaily

00:002 reports

• Cancer cells enter "zombie-like state" to evade chemotherapy, reveals new research Yahoo
• An Integrated Approach to Cervical Cancer Prevention Based on WHO’s 90-70-90 Targets: A Rural Community-Based Study Cureus